StockData
908 Devices Inc. logo

908 Devices Inc. (MASS) stock

MASSNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3030% above fair value
$10.06+0.08 (+0.75%)

Close on Nov 11, 2026Market cap $415.82MP/E –Yield –

908 Devices Inc. grew revenue 23.7% to $65.79M over the twelve months to Sep 30, 2026. Free cash flow was $2.62M. At the latest close the market valued the company at $415.82M.

Revenue
$65.79M
+23.7% vs. a year earlier
Operating income
-$28.08M
TTM Q3 2026
Free cash flow
$2.62M
TTM Q3 2026
EPS, diluted
-$0.63
TTM Q3 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$415.82M
P/E ratio
–
Price to sales
6.32
Price to book
2.78
Dividend yield
–
Free cash flow yield
0.63%

Fundamentals

Revenue
$65.79M
Net income
-$24.25M
EPS, diluted
-$0.63
Free cash flow
$2.62M
Book value per share
$3.65
Diluted shares
41M

Trading

Next earnings
Mar 2, 2027 (estimated, before the open)
Previous close
$9.98
Open
$10.42
Day's range
$9.94 – $10.69
Volume
537,588
Average volume (20 days)
395,829
Index membership
Russell 2000 (since Mar 2021), Russell 3000 (since Aug 2025)
Beta (5 years)
1.72
52-week range
$5.03 – $13.35
RSI (14 days)
42.2
Volatility (1 year)
64.0%
Relative volume
1.36×
WACC
13.5%

Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.

Market cap history

Month-end market cap since 2021, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

PeriodMASSS&P 500DifferenceMASS per yearS&P 500 per year
1 month-16.5%-2.4%−14.1 pts
3 months+0.5%-1.2%+1.6 pts
Year to date+91.6%+12.3%+79.3 pts
1 year+70.7%+12.4%+58.2 pts
3 years+91.6%+78.8%+12.8 pts+24.2%+21.4%
5 years-68.6%+75.2%−143.7 pts-20.7%+11.9%

Seven years at a glance

Fiscal years 2019 to 2025 and trailing twelve months, USD

Revenue

$65.79M+23.7% YoY

Gross profit

$34.40M+32.6% YoY

Operating income

-$28.08M

Net income

-$24.25M

EPS, diluted

-$0.63

Free cash flow

$2.62M
Reported periodTrailing twelve months

Press releases

Releases 908 Devices filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Results
All press releases and earnings

About 908 Devices

Laboratory Analytical Instruments

908 Devices develops and manufactures portable devices for chemical analysis at the point of need using mass spectrometry and optical spectroscopy technologies. Its portfolio includes handheld instruments such as the MX908, ThreatID, ProtectIR, XplorIR, and VipIR, alongside sampling consumables, extended warranty plans, on-site training, and round-the-clock technical support. The business serves government and life sciences markets, providing measurement tools to civilian first responders, military personnel, hazmat teams, customs and border agents, and law enforcement officers.

Company profile, executives and history

908 Devices stock: common questions

What is 908 Devices's stock price?

MASS closed at $10.06 on Nov 11, 2026, up 0.75% on the day. Over the past 52 weeks it traded between $5.03 and $13.35.

What is 908 Devices's market cap?

908 Devices was worth $415.82M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.

What is MASS's P/E ratio?

908 Devices lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.63), so it has no meaningful P/E ratio.

How much revenue does 908 Devices make?

908 Devices reported revenue of $65.79M for the twelve months to Sep 30, 2026, up 23.7% from a year earlier.

Does 908 Devices pay a dividend?

No. 908 Devices has not paid a cash dividend over the last twelve months.

When does 908 Devices report earnings next?

908 Devices is expected to report Q4 FY2026 results on Mar 2, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.

How has MASS stock performed over the past year?

Including dividends, MASS returned +70.7% over the past year, against +12.4% for the S&P 500.

How many MASS shares are sold short?

3M shares were sold short at the latest FINRA report, 7.80% of the float, or 7.1 days of average trading volume.

Who are 908 Devices's competitors?

Companies most similar to 908 Devices by business, industry and size include HBIO, QTRX, LCTC, RPID, CTKB.

See a number that looks wrong?